Press Release CE marked assay based on well-established ELISA technology expands EUROIMMUN’s offerings for labs that seek to understand immune response to COVID-19. EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISA assay, a surrogate neutralization…
Read more
Press Release Jena / Lübeck (GER) – Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN, a PerkinElmer company. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from oncgnostics GmbH, Gyn-Tect,…
Read more
Anti-SARS-CoV-2 antibody standard preparation from the WHO now availableSince end of December 2020, the first international reference material, “First WHO Int…
Press releaseAutomatable and reliable COVID-19 test rounds out Company’s menu of offerings for acute diagnostics of the virusEUROIMMUN, a PerkinElmer, Inc.…
Press releaseCompany expands testing portfolio for acute diagnostics of COVID-19EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE mar…
Press ReleaseEUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 ProteinUnderscores importance of serological testing using…